Company & Sponsor Intelligence

University of Minnesota

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials18

Recruiting2

Completed11

Countries1

Therapeutic footprint

adhdalzheimersautismeating_disordersepilepsypain_neuropathyparkinsonsschizophreniastroke

Indexed studies

NCT02493426Single Dose Intranasal Oxytocin and Cognitive Effects in Autism
autism · United StatesPHASE2

NCT02460809Home-based Non-invasive Brain Stimulation and Hand Tracking Rehabilitation for People With Chronic Stroke
stroke · United StatesNA

NCT02722213Mindfulness & Stress Management Study for Cardiac Patients
pain_neuropathy · United StatesNA

NCT03901456Care to Plan: a Tailored Resource for Family Members of Persons With Dementia
alzheimers · United StatesNA

NCT02002819Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability
alzheimers · United StatesPHASE2

NCT06848205Percept Transitions in FOG and PD
parkinsons · United StatesNA

NCT05273164State Representation in Early Psychosis
schizophrenia · United StatesCOMPLETED

NCT03021031Circuit-Based Deep Brain Stimulation for Parkinson's Disease; Udall Clinical Core
parkinsons · United StatesENROLLING_BY_INVITATION

NCT05300295Mentorship Program for Individuals With Autism Spectrum Disorder (ASD)
autism · United StatesNA

NCT04055532Biomarkers in Neurodegenerative Diseases
alzheimers · United StatesWITHDRAWN

NCT01176565Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
stroke · United StatesPHASE3

NCT02191995Yoga in the Treatment of Eating Disorders: a Randomized Trial
eating_disorders · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →